Evidence for immune/neuroimmune disturbances as a possible root cause of a range of disorders, including neurodevelopmental disorders, is growing. Although prenatal alcohol exposure (PAE) impacts immune function, few studies to date have examined immune function in relation to long-term negative health outcomes following PAE, and most have focused on males. To fill this gap, we utilized a rat model to examine the effects of PAE on immune/neuroimmune function during early-life [postnatal day 1 (P1), P8, and P22] in PAE and control females. Due to the extensive interplay between the immune and endocrine systems, we also measured levels of corticosterone and corticosterone binding globulin (CBG). While corticosterone levels were not different among groups, CBG levels were lower in PAE offspring from P1 to P8, suggesting a lower corticosterone reservoir that may underlie susceptibility to inflammation. Spleen weights were increased in PAE rats on P22, a marker of altered immune function. Moreover, we detected a unique cytokine profile in PAE compared to control offspring on P8 -higher levels in the PFC and hippocampus, and lower levels in the hypothalamus and spleen. The finding of a specific immune signature in PAE offspring during a sensitive developmental period has important implications for understanding the basis of long-term immune alterations and health outcomes in children with Fetal Alcohol Spectrum Disorder (FASD). Our findings also highlight the future possibility that immune-based intervention strategies could be considered as an adjunctive novel therapeutic approach for individuals with FASD.
Introduction
There is increasing evidence for immune and neuroimmune abnormalities in the etiology and pathophysiology of numerous neurodevelopmental disorders including schizophrenia (Noto et al., 2015) and autism spectrum disorder (ASD) (Krakowiak et al., 2015) . Evidence for underlying immune/neuroimmune abnormalities in Fetal Alcohol Spectrum Disorder (FASD), which includes the broad range of deficits/disorders that arise following in utero alcohol exposure, is also emerging [reviewed in (Drew and Kane, 2014) ]. Children with FASD have a higher incidence of both minor (e.g., recurrent otitis media, respiratory infections), and major, (e.g., sepsis) infections compared to non-exposed children (Gauthier et al., 2004; Johnson et al., 1981) as well as an increased incidence of malignancies, including cancers of embryonic origin (neuroblastoma, ganglioneuroblastoma, medulloblastoma) [reviewed in (Gottesfeld and Abel, 1991) ], and leukemias (Latino-Martel et al., 2010) . Animal models of prenatal alcohol exposure (PAE) support and extend the clinical findings. Increased susceptibility to infections (Grossmann et al., 1993; McGill et al., 2009 ) and malignancies (Gottesfeld and Abel, 1991), deficits in immune organ development (Bray et al., 1993; Ewald and Frost, 1987; Ewald and Walden, 1988; Redei et al., 1989) , decreased splenic lymphocyte, T lymphoblast, and B cell proliferative responses to stimulation (Gottesfeld et al., 1990; Jerrells and Weinberg, 1998; Weinberg and Jerrells, 1991; Wolcott et al., 1995) , blunted LPS-induced febrile responses (Taylor et al., 1999) , dampened cytokine responses to immune challenge (Chiappelli et al., 1997; Kim et al., 1999; Lee and Rivier, 1993) , and a more severe and prolonged course of inflammation in an adjuvantinduced arthritis model (Zhang et al., 2012) have been reported in models of in utero alcohol exposure [reviewed in Bodnar and Weinberg, 2013] .
It is well established that chronic alcohol consumption increases proinflammatory cytokine levels (Crews et al., 2006; He and Crews, 2008) . In this context, if alcohol is consumed during pregnancy, the developing fetus is likely exposed not only to
